Zidrou, 71 patient vitamin D sufficiency study: 18% lower progression [p=0.26] and 38% lower hospitalization [p=0.16] https://c19p.org/zidrou
copied to clipboard
The Relationship Between Vitamin D Status and the Clinical Severity of COVID-19 Infection: A Retrospective Single-Center Analysis
et al., Cureus, doi:10.7759/cureus.22385
Retrospective 71 hospitalized COVID-19 patients in Greece with vitamin D levels measured within 48 hours of admission, showing longer hospitalization, more radiographic findings, and higher inflammatory and cellular damage markers with vitamin D deficiency. Differences were only statistically significant for troponin and PCT.
|
risk of death, 26.4% lower, RR 0.74, p = 1.00, high D levels (≥20ng/ml) 2 of 25 (8.0%), low D levels (<20ng/ml) 5 of 46 (10.9%), NNT 35.
|
|
radiographic changes, 18.2% lower, RR 0.82, p = 0.26, high D levels (≥20ng/ml) 16 of 25 (64.0%), low D levels (<20ng/ml) 36 of 46 (78.3%), NNT 7.0.
|
|
hospitalization time, 37.7% lower, relative time 0.62, p = 0.16, high D levels (≥20ng/ml) 25, low D levels (<20ng/ml) 46.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Zidrou et al., 2/19/2022, retrospective, Greece, Europe, peer-reviewed, 6 authors, study period August 2020 - October 2020.
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.